Corrigendum to Transcranial magnetic stimulation follow-up study in early Parkinson's disease: A decline in compensation with disease progression? [Mov Disord 30, (2015), 1098-1106] DOI: 10.1002/mds.26167;Transcranial magnetic stimulation follow-up study in early Parkinson's disease: A decline in compensation with disease progression?

Movement Disorders

Volumn 30, Issue 8, 2015, Pages 1098-1106

  Kojovic, Maja ^a,b   Kassavetis, Panagiotis ^a   Bologna, Matteo ^c   Pareés, Isabel ^a   Rubio Agusti, Ignacio ^d   Beraredelli, Alfredo ^c   Edwards, Mark J ^a   Rothwell, John C ^a   Bhatia, Kailash P ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Parkinson's disease; PAS; progression; sensorimotor cortical plasticity; transcranial magnetic stimulation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CORTICAL SILENT PERIOD; DISEASE COURSE; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; HEMISPHERE; HUMAN; MALE; MIDDLE AGED; MOTOR CORTEX; MOTOR DYSFUNCTION; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; SHORT INTERVAL INTRACORTICAL INHIBITION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE; MOTOR EVOKED POTENTIAL; NERVE CELL INHIBITION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; DISEASE PROGRESSION; EVOKED POTENTIALS, MOTOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; NEURAL INHIBITION; NEURONAL PLASTICITY; PARKINSON DISEASE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84924038947     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26504     Document Type: Erratum

References (56)

1. Boroojerdi B, Kopylev L, Battaglia F, et al. Reproducibility of intracortical inhibition and facilitation using the paired-pulse paradigm. Muscle Nerve 2000;23:1594-1597.
2. Fratello F, Veniero D, Curcio G, et al. Modulation of corticospinal excitability by paired associative stimulation: reproducibility of effects and intraindividual reliability. Clin Neurophysiol 2006;117:2667-2674.
3. Muller-Dahlhaus JF, Orekhov Y, Liu Y, Ziemann U . Interindividual variability and age-dependency of motor cortical plasticity induced by paired associative stimulation. Exp Brain Res 2008;187:467-475.
4. Stefan K, Wycislo M, Classen J . Modulation of associative human motor cortical plasticity by attention. J Neurophysiol 2004;92:66-72.
5. Ridding MC, Inzelberg R, Rothwell JC . Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 1995;37:181-188.
6. Bares M, Kanovsky P, Klajblova H, Rektor I . Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study. Eur J Neurol 2003;10:385-389.
7. Strafella AP, Valzania F, Nassetti SA, et al. Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study. Clin Neurophysiol 2000;111:1198-1202.
8. Buhmann C, Gorsler A, Baumer T, et al. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease. Brain 2004;127:2732-2746.
9. Wassermann EM . Variation in the response to transcranial magnetic brain stimulation in the general population. Clin Neurophysiol 2002;113:1165-1171.
10. Sale MV, Ridding MC, Nordstrom MA . Factors influencing the magnitude and reproducibility of corticomotor excitability changes induced by paired associative stimulation. Exp Brain Res 2007;181:615-626.
11. Stinear JW, Hornby TG . Stimulation-induced changes in lower limb corticomotor excitability during treadmill walking in humans. J Physiol 2005;567:701-711.
12. Cicinelli P, Traversa R, Bassi A, Scivoletto G, Rossini PM . Interhemispheric differences of hand muscle representation in human motor cortex. Muscle Nerve 1997;20:535-542.
13. Priori A, Oliviero A, Donati E, Callea L, Bertolasi L, Rothwell JC . Human handedness and asymmetry of the motor cortical silent period. Exp Brain Res 1999;128:390-396.
14. Ridding MC, Flavel SC . Induction of plasticity in the dominant and non-dominant motor cortices of humans. Exp Brain Res 2006;171:551-557.
15. Maeda F, Gangitano M, Thall M, Pascual-Leone A . Inter- and intra-individual variability of paired-pulse curves with transcranial magnetic stimulation (TMS). Clin Neurophysiol 2002;113:376-382.
16. Kukowski B, Haug B . Quantitative evaluation of the silent period, evoked by transcranial magnetic stimulation during sustained muscle contraction, in normal man and in patients with stroke. Electromyogr Clin Neurophysiol 1992;32:373-378.
17. Orth M, Rothwell JC . The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse. Clin Neurophysiol 2004;115:1076-1082.
18. Kojovic M, Bologna M, Kassavetis P, et al. Functional reorganization of sensorimotor cortex in early Parkinson disease. Neurology 2012;78:1441-1448.
19. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-2170.
20. Espay AJ, Li JY, Johnston L, Chen R, Lang AE . Mirror movements in parkinsonism: evaluation of a new clinical sign. J Neurol Neurosurg Psychiatry 2005;76:1355-1358.
21. Li JY, Espay AJ, Gunraj CA, et al. Interhemispheric and ipsilateral connections in Parkinson's disease: relation to mirror movements. Mov Disord 2007;22:813-821.
22. Bland JM, Altman DG . Calculating correlation coefficients with repeated observations: Part 1—Correlation within subjects. BMJ 1995;310:446.
23. Ziemann U . TMS and drugs. Clin Neurophysiol 2004;115:1717-1729.
24. Di Lazzaro V, Pilato F, Dileone M, et al. GABAA receptor subtype specific enhancement of inhibition in human motor cortex. J Physiol 2006;575:721-726.
25. MacKinnon CD, Gilley EA, Weis-McNulty A, Simuni T . Pathways mediating abnormal intracortical inhibition in Parkinson's disease. Ann Neurol 2005;58:516-524.
26. Ni Z, Bahl N, Gunraj CA, Mazzella F, Chen R . Increased motor cortical facilitation and decreased inhibition in Parkinson disease. Neurology 2013;80:1746-1753.
27. Priori A, Berardelli A, Inghilleri M, Accornero N, Manfredi M . Motor cortical inhibition and the dopaminergic system: pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 1994;117:317-323.
28. Nakashima K, Wang Y, Shimoda M, Sakuma K, Takahashi K . Shortened silent period produced by magnetic cortical stimulation in patients with Parkinson's disease. J Neurol Sci 1995;130:209-214.
29. Berardelli A, Rona S, Inghilleri M, Manfredi M . Cortical inhibition in Parkinson's disease: a study with paired magnetic stimulation. Brain 1996;119:71-77.
30. Valls-Sole J, Pascual-Leone A, Brasil-Neto JP, Cammarota A, McShane L, Hallett M . Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson's disease. Neurology 1994;44:735-741.
31. Perretti A, De Rosa A, Marcantonio L, et al. Neurophysiological evaluation of motor corticospinal pathways by TMS in idiopathic early-onset Parkinson's disease. Clin Neurophysiol 2011;122:546-549.
32. Kacar A, Filipovic SR, Kresojevic N, et al. History of exposure to dopaminergic medication does not affect motor cortex plasticity and excitability in Parkinson's disease. Clin Neurophysiol 2013;124:697-707.
33. Siebner HR, Dressnandt J, Auer C, Conrad B . Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 1998;21:1209-1212.
34. Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R . Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain 2006;129:1059-1069.
35. Ueki Y, Mima T, Kotb MA, et al. Altered plasticity of the human motor cortex in Parkinson's disease. Ann Neurol 2006;59:60-71.
36. Kishore A, Popa T, Balachandran A, et al. Cerebellar sensory processing alterations impact motor cortical plasticity in parkinson's disease: clues from dyskinetic patients. Cereb Cortex 2014;24:2055-2067.
37. Udupa K, Chen R . Motor cortical plasticity in Parkinson's disease. Front Neurol 2013;4:128.
38. Kawashima S, Ueki Y, Mima T, Fukuyama H, Ojika K, Matsukawa N . Differences in dopaminergic modulation to motor cortical plasticity between Parkinson's disease and multiple system atrophy. PLoS One 2013;8:e62515.
39. Lee CS, Samii A, Sossi V, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol 2000;47:493-503.
40. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM . Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 1990;13:290-296.
41. Appel-Cresswell S, de la Fuente-Fernandez R, Galley S, McKeown MJ . Imaging of compensatory mechanisms in Parkinson's disease. Curr Opin Neurol 2010;23:407-412.
42. Hornykiewicz O . Biochemical aspects of Parkinson's disease. Neurology 1998;51(2 Suppl 2):S2-S9.
43. Zigmond MJ . Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism. Neurobiol Dis 1997;4:247-253.
44. Zigmond MJ, Berger TW, Grace AA, Stricker EM . Compensatory responses to nigrostriatal bundle injury: studies with 6-hydroxydopamine in an animal model of parkinsonism. Mol Chem Neuropathol 1989;10:185-200.
45. Hornykiewicz O, Kish SJ . Biochemical pathophysiology of Parkinson's disease. Adv Neurol 1987;45:19-34.
46. Bezard E, Gross CE, Brotchie JM . Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci 2003;26:215-221.
47. Boulet S, Mounayar S, Poupard A, et al. Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis. J Neurosci 2008;28:9575-9584.
48. Obeso JA, Rodriguez-Oroz MC, Lanciego JL, Rodriguez Diaz M . How does Parkinson's disease begin? The role of compensatory mechanisms. Trends Neurosci 2004;27:125-127; author reply 127-128.
49. van Nuenen BF, Helmich RC, Ferraye M, et al. Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism. Brain 2012;135:3687-3698.
50. van Nuenen BF, van Eimeren T, van der Vegt JP, et al. Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach. Mov Disord 2009;24:S703-S710.
51. Sabatini U, Boulanouar K, Fabre N, et al. Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 2000;123:394-403.
52. Spagnolo F, Coppi E, Chieffo R, et al. Interhemispheric balance in Parkinson's disease: a transcranial magnetic stimulation study. Brain Stimul 2013;6:892-897.
53. Cash RF, Murakami T, Chen R, Thickbroom GW, Ziemann U . Augmenting plasticity induction in human motor cortex by disinhibition stimulation. Cereb Cortex 2014.
54. Khedr EM, Farweez HM, Islam H . Therapeutic effect of repetitive transcranial magnetic stimulation on motor function in Parkinson's disease patients. Eur J Neurol 2003;10:567-572.
55. Khedr EM, Rothwell JC, Shawky OA, Ahmed MA, Hamdy A . Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease. Mov Disord 2006;21:2201-2205.
56. Lomarev MP, Kanchana S, Bara-Jimenez W, Iyer M, Wassermann EM, Hallett M . Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Mov Disord 2006;21:325-331.